Friday, May 16, 2014

7:30–8:30 am Registration, Breakfast, and Visit Exhibitors
8:30–8:45 Welcome
Lynn E. Taylor, MD, FACP & Nicole E. Alexander-Scott, MD, MPH, FAAP
8:45–9:30 Hepatitis C—Will We Be Ready?
Brian R. Edlin, MD
9:30–10:15 How Do We Treat HCV with DAAs in 2014?
Camilla S. Graham, MD, MPH
10:15–10:45 Looking Towards the Future: What Will HCV Treatment Be in 2015 and Beyond?
Thomas E. Sepe, MD
10:45–11:15 Break and Visit Exhibits
11:15–11:30 Adherence Strategies in the DAA Era: Promoting Treatment Success
Jeffrey P. Bratberg, PharmD, BCPS
11:30–12:00 The Economic Cost of Hepatitis C
John B. Wong, MD
12:00–1:00 pm Lunch and Poster Viewing
Turning to RI
1:00–1:15 Scope of the Problem: Modeling the Epidemiology of HCV in Rhode Island
Brandon DL Marshall, PhD
1:15–1:30 Clinical Trials as Pathway to Accessing Novel HCV Medications: Overview of What is Available in RI
Karen Tashima, MD and Thomas E. Sepe, MD
1:30–2:00 Panel Discussion and Question & Answer Session with Faculty
Moderator: Lynn E. Taylor, MD, FACP
Breakout Sessions
2:00–3:30 A. Mobilizing a Coordinated RI Response
Moderator: Paul G. Loberti, MPH

Participants: Nicole E. Alexander-Scott, MD, MPH, FAAP | Paul Fitzgerald, MSW | Omar Galarraga, PhD | Burke Gao | Elizabeth Kinnard | Brandon DL Marshall, PhD

B. Expanding Capacity to Treat: Group Treatment Approaches
Moderator: Megan Pinkston-Camp, MA, PhD

Participants: Alain H. Litwin, MD, MPH with
Greg Salgueiro, MS, RD, LDN, IC

C. A Practical Case-Based Discussion of Direct-Acting Antivirals

Arthur Y. Kim, MD
3:30–4:45 D. Evaluation of Newly Diagnosed HCV Patients:
Identification and Care of Patients with Cirrhosis
Kittichai Promrat, MD

E. Expanding Capacity to Treat: HCV Care & Treatment in Corrections
Anne C. Spaulding, MD, MPH and Bradley W. Brockmann, JD

F. HIV/HCV Coinfection
Rachel P. Baden, MD
4:45–5:00 Conference Wrap-Up and Poster Winners Announced
5:00 pm Adjourn